Learn about our #GetNaked Campaign View Campaign
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation Washington, DC—The U.S. Preventive Services Task Force’s (USPSTF) announceme...
The Peer Reviewed Cancer Research Program at the Department of Defense (DoD) has led to many significant discoveries and innovative new treatments for advanced melanoma. Ho...
The Two Largest Nonprofit Funders of Melanoma Research Applaud Committee’s Ongoing Support and Dedication to Advancing Breakthrough Melanoma Research WASHINGTON, DC &...
White Paper Seeks to Build on Progress of Last 10 Years Washington, DC – Recently the Melanoma Research Foundation (MRF) convened a summit of internationally-r...
Melanoma has been a part of my life since 2004. November 2004 I was diagnosed with Stage I cutaneous (skin) melanoma and in January 2008 I was diagnosed with ocular melanom...
I was first diagnosed with melanoma in 1996. Thanks to my primary care doctor, who identified an irregular mole on my back during a routine physical, and my dermatologist, ...
Through the Melanoma Research Foundation’s #CUREOM Unite! Campaign, Ocular Melanoma Patients Help Fund and Review Research Grant Washington, DC – T...
#GivingTuesday is almost over but it’s not too late to give a gift to the Melanoma Research Foundation (MRF) to help stop melanoma in its path. Christy and Dan share why ...
Today is #GivingTuesday! Read why Carola Supports the MRF. Melanoma is one of the fastest growing cancers in the world. Today, however, people across the globe stand...
#GivingTuesday is TOMORROW, December 1! Join Graham in Supporting the MRF. During the holiday season, we are especially grateful for the children in our lives and th...
#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF. #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...
Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...
